Related Experiment Video
Updated: Sep 1, 2025
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
318
Treatment Guidelines in Pediatric Rheumatic Diseases
Ekemini A Ogbu1, Hermine I Brunner2
1Cincinnati Children's Medical Center and University of Cincinnati, Johns Hopkins University, 3333 Burnet Avenue, MLC 4010, Cincinnati, OH 45229, USA; Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA.
Rheumatic Diseases Clinics of North America
|August 11, 2022
Summary
Treatment guidelines are scarce for pediatric rheumatic diseases due to their rarity. This review examines existing guidelines for autoimmune and autoinflammatory conditions in children, highlighting the need for more evidence-based recommendations.
Area of Science:
- Pediatric Rheumatology
- Autoimmune Diseases
- Autoinflammatory Diseases
Background:
- Treatment guidelines are crucial for managing diseases based on scientific evidence.
- Pediatric rheumatologists treat rare autoimmune and autoinflammatory conditions.
- Few treatment guidelines currently exist for pediatric rheumatic diseases.
Purpose of the Study:
- To provide an overview of existing and past treatment guidelines in pediatric rheumatology.
- To address the need for stronger evidence supporting recommendations for rare pediatric rheumatic diseases.
Main Methods:
- Literature review of past and current treatment guidelines.
- Analysis of guideline availability and evidence base in pediatric rheumatology.
Main Results:
- The field of pediatric rheumatology has a limited number of treatment guidelines.
- The rarity of these diseases hinders the development of robust evidence, such as randomized controlled studies.
- There is a significant need for improved evidence supporting treatment recommendations.
Conclusions:
- Developing comprehensive treatment guidelines for rare pediatric rheumatic diseases remains a challenge.
- Further research is needed to strengthen the evidence base for guideline recommendations.
- This review provides a foundation for understanding the current landscape of pediatric rheumatology guidelines.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
29
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
29
01:20Rheumatic Heart Disease IV: Nursing Management
33
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
33
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
48
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
48
01:26Mitral Stenosis III: Medical Management
18
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
18
01:23Rheumatic Heart Disease I: Introduction
36
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
36
01:14Myocarditis III: Medical Management
14
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14